Women in treatment in the Czech Republic Běla Studničková, M. D., Vladimír Polanecký, M. D....
-
Upload
victoria-howe -
Category
Documents
-
view
215 -
download
0
Transcript of Women in treatment in the Czech Republic Běla Studničková, M. D., Vladimír Polanecký, M. D....
Women in treatment in the Czech Republic
Běla Studničková, M. D., Vladimír Polanecký, M. D.Drug Epidemiology Headquarters
Hygienic Station of the Capital Prague
Women in treatment in the Czech Republic
System of data collection
Data provider = TC centres
Data collection provides Hygienic Service
National sumary of data and data analysis provides Drug Epidemiology Headquarters of the Hygienic Station of the Capital Prague
EMCDDA form is used
monitoring of incidence of treated drug users (First Treatment Demand – FTD) since 1.1.1995
monitoring of prevalence of treated drug users and All Treatment Demand (ATD) since 1.1.2002
Women in treatment in the Czech Republic
AgeSexDistrict of T/CDistrict of livingSource of referral Current living status Employment status Highest education level
Primary and secondary drugsRoute of AdministrationFrequency of useDuration of regular useRisk behaviour:
Curently or ever injected Shared past month or ever HIV and VH status
Initial outcome
Collected data:
Women in treatment in the Czech Republic - 2003 The age distribution of treated drug users according to sex
Age group Men Women Men : women
ratio Total %
Prevalence of women / 100 000 women
Under 15 71 38 1,9 : 1 109 1,3 4,9 15 - 19 1386 1042 1,3 : 1 2432 28,5 319,0
20 - 24 2015 918 2,2 : 1 2934 34,4 236,9
25 - 39 2142 584 3,7 : 1 2727 32,0 51,7
40 and more 208 48 4,3 : 1 256 3,0 1,8
Unknown 43 16 2,7 : 1 64 0,8 *
Total 5865 2646 2,2 : 1 8522 100 50,5
Prevalence in the year 2003
Incidence (FTD) in the year 2003
Age group Men Women Men : women
ratio Total %
Incidence of women / 100 000 women
Under 15 57 35 1,6 : 1 92 2,2 4,5 15 - 19 999 713 1,4 : 1 1716 41,3 218,1
20 - 24 897 356 2,5 : 1 1254 30,2 91,9
25 - 39 746 224 3,3 : 1 971 23,4 19,8
40 and more 63 21 3,0 : 1 84 2,0 0,8
Unknown 26 12 2,2 : 1 41 1,0 *
Total 2788 1361 2,0 : 1 4158 100 26,0
Women in treatment in the Czech Republic - 2003 The age distribution of treated heroin and Pervitin users
according to sexAll Pervitin users in the Czech Republic in the year 2003 (Prevalence)
All Pervitin users in Prague in the year 2003 (Prevalence)
Age group Men Women Men : women
ratio Total %
Prevalence of women / 100 000 women
Under 15 0 1 0 : 1 1 0,2 1,4 15 - 19 45 101 0,4 : 1 146 25,3 311,5
20 - 24 75 86 0,9 : 1 161 27,9 201,0
25 - 39 148 83 1,8 : 1 231 40,0 63,2
40 and more 27 6 4,5 : 1 33 5,7 1,8
Unknown 4 0 * 6 1,0 *
Total 299 277 1,1 : 1 578 100 45,5
Age group Men Women Men : women
ratio Total %
Prevalence of women / 100 000 women
Under 15 4 5 0,8 : 1 9 0,2 0,6 15 - 19 613 672 0,9 : 1 1288 28,7 205,6
20 - 24 1045 555 1,9 : 1 1601 35,7 143,2
25 - 39 1132 310 3,7 : 1 1442 32,1 27,4
40 and more 102 10 10,2 : 1 112 2,5 0,4
Unknown 26 9 2,9 : 1 38 0,8 *
Total 2922 1561 1,9 : 1 4490 100 29,8
Women in treatment in the Czech Republic 1995 – 2003Trends of the number and of the share
of first treated men and women
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1995 1996 1997 1998 1999 2000 2001 2002 2003
Men Women
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
1995 1996 1997 1998 1999 2000 2001 2002 2003
Num
ber o
f per
sons
Men Women
Women in treatment in the Czech Republic - 2003The share of men and women
according to groups of primary drug
0%
20%
40%
60%
80%
100%
Heroin, opiatesPervitin, stimulants
Cannabinoids
HallucinogensVolatile inhalants
Hypnotics, sedatives
Other substances
Total
Men Women
First treated clients
0%
20%
40%
60%
80%
100%
Heroin, opiatesPervitin, stimulants
Cannabinoids
HallucinogensVolatile inhalants
Hypnotics, sedatives
Other substances
Total
Men Women
All treated clients
Women in treatment in the Czech Republic – 2003 Groups of primary drug according to sex
Cannabinoids (18,96%)Hallucinogens (0,07%)Volatile inhalants (1,10%)Hypnotics, sedatives (1,40%)Other substances (0,59%)Unknown (0,00%)
Heroin, opiates (14,70%)Pervitin, stimulants (63,19%)
Women - FTDCannabinoids (13,30%)
Hallucinogens (0,11%)Volatile inhalants (0,94%)Hypnotics, sedatives (1,66%)Other substances (0,45%)Unknown (0,23%)
Heroin, opiates (23,13%)Pervitin, stimulants (60,17%)
Women - Prevalence
Cannabinoids (25,85%)
Hallucinogens (0,54%)Volatile inhalants (3,61%)
Hypnotics, sedatives (0,79%)Other substances (0,39%)Unknown (0,21%)
Heroin, opiates (16,30%)
Pervitin, stimulants (52,31%)
Men - FTD
Cannabinoids (17,89%)Hallucinogens (0,44%)Volatile inhalants (3,42%)Hypnotics, sedatives (1,02%)Other substances (0,43%)Unknown (0,22%)
Heroin, opiates (25,88%)
Pervitin, stimulants (50,70%)
Men - Prevalence
Women in treatment in the Czech Republic, 1995 - 2003 Number of first treated women with drug use
according to groups of primary drug
0
200
400
600
800
1000
1200
1400
1600
1995 1996 1997 1998 1999 2000 2001 2002 2003
Num
ber
of w
omen
Heroin, opiates Pervitin, stimulants Cannabis Hallucinogens Volatile inhalants
Women in treatment in the Czech Republic – 2003Treated drug users according to the age
<15 (2,04%)
15-19 (35,83%)
Unknown (0,93%)40 and more (2,26%)
25-39 (26,76%)
20-24 (32,17%)
<15 (2,57%)Unknown (0,88%)
40 and more (1,54%)25-39 (16,46%)
20-24 (26,16%)15-19 (52,39%)
<15 (1,21%)
15-19 (23,63%)
Unknown (0,73%)40 and more (3,55%)
25-39 (36,52%)
20-24 (34,36%)
<15 (1,44%)
15-19 (39,38%)
Unknown (0,60%)40 and more (1,81%)
25-39 (22,07%)
20-24 (34,69%)
All treated clients
Men:
Men:
Women:
Women:First treated clients
Women in treatment in the Czech Republic – 2003Treated drug users according to the labour status and sex
Regular employment (10,36%)
Unemployed (34,97%)
Unknown (1,91%)Other (2,13%)
Economically inactive (3,31%)
Pupil/Student (47,32%)
Women - FTD
Regular employment (11,94%)
Unknown (3,74%)Other (2,80%)
Economically inactive (4,23%)
Pupil/Student (34,01%)
Unemployed (43,27%)
Women - Prevalence
Regular employment (14,52%)
Unknown (3,83%)Other (1,89%)
Economically inactive (1,32%)
Pupil/Student (27,39%)
Unemployed (51,05%)
Men - FTD
Regular employment (15,30%)
Unknown (4,26%)Other (2,57%)
Economically inactive (2,44%)
Pupil/Student (17,41%)
Unemployed (58,02%)
Men - Prevalence
Women in treatment in the Czech Republic - 2003The number of women and the share of primary drugs
according to age groups
0
200
400
600
800
1000
1200
Num
ber
of w
omen
Under 15 15-19 20-24 25-39 40 and
more
Unknown
Age groups
Heroin, opiates Pervitin, stimulants Cannabinoids Hallucinogens
Volatile inhalants Hypnotics, sedatives Other substances Unknown
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Under 15 15-19 20-24 25-39 40 and
more
Unknown
Age groups
Heroin, opiates Pervitin, stimulants Cannabinoids Hallucinogens
Volatile inhalants Hypnotics, sedatives Other substances Unknown
Women in treatment in the Czech Republic, 1995 - 2003 First treated women with drug use
according to age groups
0%
20%
40%
60%
80%
100%
1995 1996 1997 1998 1999 2000 2001 2002 2003
under 15 15-19 20-24 25-39 40 and more unknown
Women in treatment in the Czech Republic – 2003Groups of primary drug according to regions - Prevalence
0
50
100
150
200
250
300
Nu
mb
er o
f w
om
en
PragueCentral Bohemia
Southern Bohemia
PlzenCarlsbad
Usti nad Labem
LiberecHradec Kralove
Pardubice
JihlavaSouth Moravia
Olomouc
ZlinMoravskoslezsky
HallucinogensOther substances
Volatile inhalantsCannabis
Heroin,opiatesPervitin,stimul.
Women in treatment in the Czech Republic – 2003Groups of primary drug according to regions - FTD
0
20
40
60
80
100
120
140
Nu
mb
er o
f w
om
en
PragueCentral Bohemia
Southern Bohemia
PlzenCarlsbad
Usti nad Labem
LiberecHradec Kralove
Pardubice
JihlavaSouth Moravia
Olomouc
ZlinMoravskoslezsky
HallucinogensOther substances
Volatile inhalantsCannabis
Heroin,opiatesPervitin,stimul.
Women in treatment in the Czech Republic – 2003 Average age of treated clients according to sex
16
17
18
19
20
21
22
23
24
25
26
Ag
e
Heroin Pervitin Marihuana Toluen, other inhalants
FTD - Men FTD - Women Prevalence - Men Prevalence - Women
Women in treatment in the Czech Republic – 2003Route of administration of primary drug according to sex
Other / Unknown (0,81%)Inhalation (13,30%)
Smoking (20,87%)
Oral (3,38%)
Inject (61,65%)
Women - FTD
Other / Unknown (1,51%)Inhalation (10,20%)
Smoking (15,00%)
Oral (4,12%)
Inject (69,16%)
Women - Prevalence
Other / Unknown (1,30%)Inhalation (11,02%)
Smoking (28,45%)
Oral (2,01%)
Inject (57,21%)
Men - FTD
Other / Unknown (1,45%)Inhalation (10,77%)
Smoking (19,08%)
Oral (3,05%) Inject (65,66%)
Men - Prevalence
Women in treatment in the Czech Republic – 2003Primary and secondary drugs used by women
FTD Prevalence
0 400 800 1200 1600 2000 Number of persons
Subutex
Psilocybine
metadon
brown
Other substances
Cocaine
Hypnotics, sedatives
LSD
Benzodiazepines
Other opiates
Volatile inhalants
Alcohol with drug
Ecstasy
Heroin
Marihuana
Pervitin
Primary drug Secondary drug
Note: Only drugs used by 15 and more women.
0 200 400 600 800 1000 Number of persons
Subutex
Psilocybine
metadon
brown
Other substances
Cocaine
Hypnotics, sedatives
LSD
Benzodiazepines
Other opiates
Volatile inhalants
Alcohol with drug
Ecstasy
Heroin
Marihuana
Pervitin
Primary drug Secondary drug
Women in treatment in the Czech RepublicCONCLUSIONS:
• The highest number of treated women is in the age group 15 – 19 years
• The men : women ratio is lowest in both youngest age groups, in pervitin users in the Czech Republic is lower then 1 : 1 (in Prague in 3 youngest age groups)
• The trend of number of treated women is still increasing
• Treated women use pervitin more often then men
• Treated women are younger then men (55 % of all treated women are younger then 20 years) and they are more commonly in category „pupil / student“
• The share of pervitin use and heroin use among women grows with older age group; the share of cannabinoids use decreases
• The average age of treated women using heroin and opiates is about two years lower in comparison with men, in pervitin the difference is 3,5 years
• The share of treated women with inject administration of drug is about 4 % higher in comparison with men
Thanks for your attention!